The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

Get real-time updates on health from celebrity fitness secrets and weight loss breakthroughs to nutrition advice, get your ...

Recent research found that eating cheese can lower the risk of developing sleep apnea. Experts explain the link but warn ...

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for ...

You don’t realize that you could be sleeping for eight hours but when you get tested you actually only slept for one or two.” ...

Following the evaluation of projects that advanced to the final stage and underwent the implementation phase, winners were selected based on criteria including creativity ... aims to broaden its ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

Our take: The Fitbit Inspire 3 is a great sleep tracker for someone who wants to measure physical activity and sleep data without a bulky device on their wrist. This Fitbit’s sleek design ...